Oura, the smart ring maker, has agreed to buy Counsel Health, an AI-native primary care company, for $625 million in cash, subject to purchase price adjustments. Its release on 10 November says the deal is expected to close before the end of the calendar year.
In the same release Oura gave preliminary, unaudited results: revenue for the quarter ended 30 September 2026 grew 153 percent year over year to $533 million. By our arithmetic from Oura’s own S-1 filing, that 153% is measured against $210.3 million, the lowest of the eight quarters on file.
Business Pill · AI Agents Explained
An evergreen Business Engineer explainer on AI agents. It teaches the general idea only and does not discuss Oura or Counsel Health.
The key insight: Oura agreed on 10 November to buy AI-native primary care company Counsel Health for $625 million in cash and reported 153 percent revenuegrowth to $533 million for the quarter ended 30 September 2026 (preliminary, unaudited). By our arithmetic from its S-1, the comparison quarter, $210.3 million, is the lowest of the eight quarters on file, and growth was 74% the quarter before.
Oura says Counsel “combines medical AI with in-house physicians to deliver immediate, high-quality guidance and care”. Members can chat with Counsel’s medical AI and, when needed, escalate to a board-certified Counsel physician within minutes, all inside the Oura App.
The two companies already had a partnership, which the release says they plan to build on. Oura says that among members using Counsel, more than 90 percent of those surveyed say their Oura data helped them get better care, and members who saw a Counsel physician rated their care 4.6 out of 5.
Counsel’s platform runs on what the release calls “a clinical AI harness that invokes specialized agents for tasks such as medical history-taking, guideline retrieval, records review, and emergency detection”. After the deal, Counsel will keep serving its enterprise partners, which Oura lists as health plans, health systems, consumer health organizations and employers.
Oura total revenue per quarter, $ millions, fiscal year ending 30 September. Quarters to June 2026 from Oura’s S-1/A of 21 September 2026; the September 2026 quarter is preliminary and unaudited, from Oura’s 10 November release. Year-over-year growth under each bar is our arithmetic.
How Oura Explains the Price
Executive chairman David Shuman tied the price directly to growth. “Oura’s record growth of 153 percent this quarter and our over six million members provides us the confidence to invest $625 million cash to acquire Counsel Health”, he said in the release.
Chief executive Tom Hale said the two companies can “create a new model of care that extends the current healthcare paradigm”. Counsel founder and chief executive Muthu Alagappan said the teams “negotiated our deal over the past few months”.
The 153% Against Oura’s Own Filing
Oura’s amended S-1, filed on 21 September before the company postponed its IPO on 29 September, lists quarterly revenue back to December 2024. The quarter ended 30 September 2025 brought in $210.3 million. The three quarters before it brought in $230.7 million, $232.6 million and $234.3 million.
By our arithmetic, year-over-year growth ran at 95% in the December 2025 quarter, 53% in March 2026 and 74% in June 2026, then 153% in September 2026. The jump from 74% to 153% is 79 percentage points, and part of it comes from the low base: the September 2025 dip was in hardware, which fell to $160.7 million from $190.0 million the quarter before, while membership revenue kept rising.
Measured in dollars, the September 2026 quarter’s $533 million is $124 million above the June 2026 quarter, by our arithmetic. For the full fiscal year, Oura says revenue was approximately $1.75 billion, up 92 percent, and the S-1 put fiscal 2025 revenue at $907.9 million.
What $625 Million Means Against Oura’s Numbers
By our arithmetic, the cash price is about 1.2 times Oura’s September-quarter revenue and about 36% of its fiscal 2026 revenue. Oura says the quarter delivered $87 million of Adjusted EBITDA, a 16 percent margin, so the price equals about 7.2 quarters of Adjusted EBITDA at that rate.
The S-1 put cash and cash equivalents at $371.8 million on 30 June 2026, with $375.0 million borrowed under the revolving credit facility. The $625 million price is about 1.7 times that June cash balance, by our arithmetic. Oura has not published its 30 September balance sheet or said how it will fund the payment.
As we read the release, Oura is pricing the deal off its growth: its executive chairman links the $625 million directly to the 153 percent quarter and over six million members. Our arithmetic shows that quarter was compared with a hardware dip a year earlier, so the step-up from 74% growth partly reflects an easy base.
David Shuman, executive chairman of Oura, in the release
“This combination expands our addressable market and deepens the value we deliver to every member.”
Three Implications
FOR OURA MEMBERS Oura says members can chat with Counsel’s medical AI and escalate to a board-certified Counsel physician within minutes inside the Oura App.
FOR OURA’S BALANCE SHEET The S-1 put cash at $371.8 million on 30 June 2026 with $375.0 million drawn on its revolving credit facility; the $625 million cash price is about 1.7 times that June cash, by our arithmetic. Oura has not said how it will fund the payment.
FOR COUNSEL’S PARTNERS Oura says Counsel will continue to serve existing and new enterprise partners, which it lists as health plans, health systems, consumer health organizations and employers.
FOR THE CLOSING Oura says the transaction is expected to close before the end of the calendar year, subject to customary closing conditions.
The framework argues: “The transformer is a commodity now; what changes between paradigms is where intelligence accumulates and who can capture it”.
As we read it, the deal joins Oura’s continuous biometric data with Counsel’s clinical AI and physicians in one app. The framework predates this deal and does not discuss Oura or Counsel.
What Is Not Established
Oura has not disclosed Counsel’s revenue, patient numbers or valuation history, its own 30 September cash balance, or how the $625 million will be funded. The fourth-quarter and fiscal-year figures are preliminary and unaudited, and Oura says they may change as it completes its year-end close and audit. The release does not mention Oura’s postponed IPO. Bloomberg’s full report was not read for this piece; its headline matches the release.
This Week In The AI Supercycle
The Great Convergence of Capital, Power, and Geopolitics
This week’s issue: for two years the AI build-out was priced as a supply story, and last week as a credit story. This week it was priced as a permission story, and the answer arrived as a cost, not a ban.
Oura agreed to pay $625 million in cash for Counsel Health and reported 153 percent growth to $533 million in its September quarter. By our arithmetic from its S-1, that growth is measured against $210.3 million, the lowest of eight quarters on file, after 74% growth the quarter before.
95,000+ executives read Business Engineer for the AI strategy frameworks cited by ChatGPT, Claude, and Perplexity.
A note on sourcing. Deal terms, quotations and fiscal 2026 figures come from Oura’s 10 November release, distributed on Business Wire; the September 2026 quarter figures are preliminary and unaudited. Earlier quarterly revenue, cash and debt come from Oura’s amended S-1 filed with the SEC on 21 September 2026. Growth rates and ratios are our arithmetic. Bloomberg is cited for its headline only.
Gennaro Cuofano is a CRO and tech executive who has worked in AI since late 2015, starting with bringing NLP, natural-language generation, voice and chatbot products to the marketing industry. His background is in law and finance: he holds a Master's degree in Law and an International MBA with an emphasis on corporate finance (LUISS Business School and the University of San Diego, 2012), and worked as a financial analyst at a real-estate investment firm in San Diego and as an assistant controller. His work focuses on business model strategy, business engineering and, more broadly, structural analysis: how companies make money, read from their own filings. He created FourWeekMBA and leads research there and at The Business Engineer, his newsletter on AI and business strategy, with over 95,000 subscribers and more than 1,000 published analyses. His writing has also appeared on Entrepreneur (for example, How to Digitize a Family Business in Europe) and HackerNoon. Find him on LinkedIn and Substack. See how we source.
